Gastroenterology
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
From the Journals
Liver disease gets new name and diagnostic criteria
Formerly known as nonalcoholic fatty liver disease, the condition will now be known as metabolic dysfunction–associated steatotic liver disease (...
Latest News
Higher alcohol consumption linked to early-onset CRC
Compared with light drinking, moderate and heavy drinking were associated with a significantly elevated risk of early-onset CRC.
Latest News
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
“GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis,” but additional studies are needed to confirm the results, the...
Conference Coverage
Survodutide impresses in phase 2 weight loss trial
Survodutide has received U.S. Food and Drug Administration Fast Track Designation for adults with NASH.
Sponsored Supplement
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
From the Journals
Is there a link between esophageal risk and sleep habits?
Too much or too little sleep, daytime naps, and other sleep patterns may increase the risk of developing esophageal cancer.
Latest News
FDA OKs Suflave, a lower-volume colonoscopy prep drink
Most patients reported that Suflave was “tolerable to very easy” to consume and indicated they would request it for a subsequent colonoscopy.
Latest News
WHO plans to declare common sweetener as possible carcinogen
Aspartame would join the “possibly” carcinogenic group, which includes gasoline engine exhaust and working as a dry cleaner.
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
Latest News
MRI identifies rectal cancer patients who can skip CRT
Study suggests that neoadjuvant chemoradiation therapy can be restricted to patients at high risk of locoregional recurrence.
From the Journals
Colorectal cancer: Younger patients fare worse
Genetic data also showed increased prevalence of certain mutations in early-onset patients.